ClinicalTrials.gg
RecruitingNCT07878273Updated Oct 16, 2026

Tibial Nerve Size and Clinical Features in Chronic Plantar Fasciitis

An observational study in Plantar Fasciitis, Chronic and Tibial Nerve, sponsored by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey · Observational

From the registry’s dates

  • Started Sep 2026; still recruiting 1 month later.
Updated Oct 16, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
102
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This cross-sectional observational study aims to examine the relationship between tibial nerve cross-sectional area at the tarsal tunnel and plantar fascia thickness, pressure pain threshold, foot posture, and functional status in individuals with chronic plantar fasciitis. Ultrasound measurements and clinical assessments will be used to explore whether tibial nerve morphology is associated with structural, pain-related, and functional findings. The findings may improve understanding of chronic plantar fasciitis and inform future prospective research.

Read the detailed description

In patients with plantar fasciitis, pain and functional loss are mostly associated with plantar fascia pathology. However, in some patients, the severity of pain and functional impairment may not be fully explained by the thickness of the plantar fascia. This situation suggests that foot posture, pain sensitivity, and possible tibial nerve involvement may contribute to the clinical picture, especially in chronic plantar fasciitis.

The evaluation of the relationship between the cross-sectional area of the tibial nerve and clinical and functional findings in patients with chronic plantar fasciitis may contribute to a more comprehensive understanding of plantar fasciitis. With this study, it will be investigated whether the evaluation of not only the thickness of the plantar fascia but also the morphology of the tibial nerve at the tarsal tunnel level is clinically significant in plantar fasciitis. Due to the observational, cross-sectional nature of our study, it is not possible to establish a cause-and-effect relationship; however, determining the relationship between the cross-sectional area of the tibial nerve and the thickness of the plantar fascia and pain will provide data that could serve as a basis for examining the cause-and-effect relationship prospectively in the future. The results obtained may contribute to identifying focal points in the treatment of plantar fasciitis.

02

Conditions studied

  • Plantar Fasciitis, Chronic
  • Tibial Nerve

Browse trials for

Keywords

  • plantar fasciitis
  • tibial nerve
  • foot posture
03

In context

Fasciitis, Plantar

273 studies on the registry are indexed under Fasciitis, Plantar; 71 are open to participants now.

This study's planned enrollment of 102 is above the median of 64 across 29 observational studies indexed under Fasciitis, Plantar.

Browse Fasciitis, Plantar studies →

Lead sponsor

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey is the lead sponsor of 107 studies on the registry; 31 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Individuals applying to the Physical Medicine and Rehabilitation Clinic of Sultan 2. Abdülhamid Han Training and Research Hospital will be evaluated, and those who meet the inclusion criteria for the groups and sign the voluntary consent form will be included in the study.

Eligibility criteria

  1. Chronic Plantar Fasciitis Group:

    Inclusion Criteria:

    • Be between the ages of 18-65
    • Have heel pain that has been ongoing for at least 6 months, especially noticeable during the first few steps after getting up in the morning
    • Have tenderness upon palpation of the medial calcaneal tubercle
    • Have read and signed the volunteer consent form (VCF)

    Exclusion Criteria:

    • Being under 18 or over 65 years old
    • Having a history of physical therapy, injection, radiation, or surgery targeting the plantar fascia or tibial nerve within the last 6 months
    • Calcaneus fracture, tumour, or cyst related to the plantar fascia
    • Lumbosacral radiculopathy, polyneuropathy
    • Rheumatic diseases such as rheumatoid arthritis, ankylosing spondylitis, gout
    • Foot and ankle osteoarthritis
    • Presence of osteomyelitis or skin infection in the foot
    • Systemic diseases such as kidney and liver failure, diabetes, peripheral arterial vascular disease
    • Pregnancy
  2. Healty-control-group

Inclusion Criteria:

  • Being completely healthy
  • Being between 18 - 65 years old
  • Having read and signed the Volunteer Consent Form (BGOF)

Exclusion Criteria:

  • Being under 18 or over 65 years old
  • Having any acute or chronic disease
  • Pregnancy
05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
102 participants (estimated)
Patient registry
No

Groups and cohorts

  • Chronic Plantar Fasciitis Group

    Patients with plantar fasciitis

    Other: Pressure Pain Threshold Assessment · Other: Plantar fascia ultrasonographic Assessment · Other: Tibial nerve ultrasonographic assessment

  • Healthy Volunteers (control group)

    Healthy Volunteers

    Other: Pressure Pain Threshold Assessment · Other: Plantar fascia ultrasonographic Assessment

Interventions

  • OtherPressure Pain Threshold Assessment

    Pressure pain threshold measurements will be performed using a pressure algometer to assess pain sensitivity.

    Also known as: PPT

  • OtherPlantar fascia ultrasonographic Assessment

    Ultrasonographic evaluation will be performed to measure plantar fascia thickness

    Also known as: US

  • OtherTibial nerve ultrasonographic assessment

    Ultrasonographic evaluation will be performed to assess tibial nerve cross sectional area in tarsal tunnel.

    Also known as: US

06

What researchers measure

Primary outcomes

  1. Assessment of tibial nerve cross-sectional area with ultrasonographic evaluation

    The tibial nerve image will be obtained from within the tarsal tunnel and will be visualised by holding it with a prop at minimum pressure next to the medial malleolus, under the flexor retinaculum, alongside the artery-venous bundle. Three measurements will be taken for the nerve cross-sectional area, and the mean will be calculated. An independent researcher will code and record all obtained images, and the images will be analysed using the ImageJ offline DICOM software 1.8 ® (National Institute of Health, Bethesda, MD, USA, v.1.53a).

    Time frame: baseline

Secondary outcomes

  1. Pressure Pain Threshold - calcaneus

    Pressure pain threshold is defined as the minimal pressure level that causes pain. The measurement will be applied twice with a 1-minute interval, and the average of these applications will be recorded. A trial test will be conducted on the patient before the actual test. Pressure will be applied with a pressure algometer until pain is induced, and the test will be terminated when the patient feels pain. The measurement will be taken from the calcaneus bone (the attachment point of the plantar fascia) using a Wagner manual pressure algometer (1 cm² probe-10 kg/20 lb).

    Time frame: Baseline

  2. Numeric Pain Rating Scale, NPRS

    Pain severity will be evaluated using a scale rated from 0 (no pain) to 10 (unbearable pain). Participants will be asked to rate the pain felt with the first step after waking up in the morning and the average pain level over the past week.

    Time frame: baseline

  3. Foot Posture Index

    The participant's foot will be observationally scored based on six anatomical criteria in a standing natural posture, and the total score will be recorded.

    Time frame: baseline

  4. Short Form-12 (SF-12)

    Physical Component Summary and Mental Component Summary

    Time frame: Baseline

  5. Foot Function Index

    The Foot Function Index is a self-report-based scale developed to evaluate the effects of foot and ankle-related problems on pain, functional limitation, and daily life activities in individuals, with its validity and reliability demonstrated. FFI consists of three sub-dimensions: pain, disability (functional limitation), and activity limitation. The scale allows individuals to evaluate foot-related problems they have experienced recently in the context of daily life activities. Each sub-dimension and total score reflect the level of impairment in foot functions. Increasing FFI scores indicate that the severity of foot pain and the limitations in foot functions have increased, thereby negatively affecting foot-related quality of life. FFI is widely used in clinical and research settings to evaluate the functional effects of foot pathologies.

    Time frame: baseline

  6. Thickness of the plantar fascia in ultrasonographic imaging

    In the study, the evaluation with ultrasound will be conducted while the participants are in a prone position on the examination table, with their feet hanging off the table and in a dorsiflexed position. A linear probe will be placed longitudinally over the medial tubercle of the calcaneus to ultrasonographically examine the plantar fascia thickness (PFT). PFT will be measured 1 cm distal to the calcaneus attachment point. A PFT of 4 mm or greater will be considered evidence of fasciitis. It has been shown that this measurement technique has good intra-rater reliability. The Sonosite M-Turbo device will be used for ultrasonography and will be performed by a physical therapy and rehabilitation specialist with 10 years of experience.

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
  • Sultan Abdülhamid Han Eğitim ve Araştırma Hastanesi
    Istanbul, Turkey (Türkiye)
    Recruiting
08

References and documents

Publications

  • Alshami AM, Souvlis T, Coppieters MW. A review of plantar heel pain of neural origin: differential diagnosis and management. Man Ther. 2008 May;13(2):103-11. doi: 10.1016/j.math.2007.01.014. Epub 2007 Mar 30. PubMed 17400020 ↗
  • Labib SA, Gould JS, Rodriguez-del-Rio FA, Lyman S. Heel pain triad (HPT): the combination of plantar fasciitis, posterior tibial tendon dysfunction and tarsal tunnel syndrome. Foot Ankle Int. 2002 Mar;23(3):212-20. doi: 10.1177/107110070202300305. PubMed 11934063 ↗
  • Chang CW, Wang YC, Hou WH, Lee XX, Chang KF. Medial calcaneal neuropathy is associated with plantar fasciitis. Clin Neurophysiol. 2007 Jan;118(1):119-23. doi: 10.1016/j.clinph.2006.09.028. Epub 2006 Nov 13. PubMed 17095287 ↗
  • Sabir N, Demirlenk S, Yagci B, Karabulut N, Cubukcu S. Clinical utility of sonography in diagnosing plantar fasciitis. J Ultrasound Med. 2005 Aug;24(8):1041-8. doi: 10.7863/jum.2005.24.8.1041. PubMed 16040817 ↗
  • Xiong S, Goonetilleke RS, Jiang Z. Pressure thresholds of the human foot: measurement reliability and effects of stimulus characteristics. Ergonomics. 2011 Mar;54(3):282-93. doi: 10.1080/00140139.2011.552736. PubMed 21390958 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2026 (actual). Primary completion is estimated for Dec 2026, 2 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 9, 2026
First posted
Oct 16, 2026
StartActual
Sep 7, 2026
Primary completionEst.
Dec 1, 2026
CompletionEst.
Dec 1, 2026
Last update
Oct 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07878273
Responsible party
Feyza Nur Yucel (Associate Professor, Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey) — Principal investigator
First posted
Oct 16, 2026
Start date
Sep 7, 2026
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 1, 2026 (estimated)
Last update
Oct 16, 2026

Study contacts

Feyza Nur Yücel, Assoc. Prof.
Contact
dr.fny28@gmail.com
2165422000 ext. +90
Feyza Nur Yücel, Assoc. Prof.
study director · Saglik Bilimleri Universitesi

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion